XBIT
XBIT
NASDAQ · Biotechnology

Xbiotech Inc

$1.91
+0.02 (+1.06%)
As of Nov 14, 2:28 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +526.7% upside
Low Target $8.96
Average Target $11.97
High Target $15.34
Current Price $1.91
Current
$1.91
Target
$11.97
$8.96 $11.97 avg $15.34
Scenario Analysis
Bear Case
$8.96
369.1%
Low target
Base Case
$11.97
+526.7%
Avg target
Bull Case
$15.34
+703.1%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$3.06
-37.6% from high
52-Week Low
$1.80
+6.1% from low
Target vs 52W High
$11.97
+291.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.7%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.6%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -92.0%
MRNA
Moderna Inc
Hold 31 32% $149.45 -33.1%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.2%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -33.8%